Cytochalasin B, an alkaloid that inhibits a wide variety of cellular movements, interacts with actomyosin, the contractile protein complex of striated muscle. This interaction causes a decrease in viscosity of the actomyosin complex and an inhibition of acto-heavy meromyosin ATPase activity of at least 60%. Cytochalasin B does not affect the viscosity of myosin nor the ATPase activity of heavy meromyosin, suggesting that the drug might interact directly with the actin moiety of the actomyosin complex. Indeed, as judged by viscometry, there is a strong interaction of cytochalasin B with actin, at nearly stoichiometric concentrations. Myosin appears to compete with cytochalasin for binding to actin. (1), including blood platelets (2, 3), leucocytes (4), mammalian brain (5), sarcoma cells (6), seaurchin eggs (7), Acanthamoeba castellanii (8), plasmodia of the acellular slime mold, Physarum polycephalum (9-11), amoebae of the cellular slime mold, Dictyostelium discoideum (12), and most recently in epithelial cells of the chicken intestine (13). The similarity of these actin-like proteins with muscle actin is emphasized by the observations (11-16) that they interact with muscle heavy meromyosin (HMM) to give "arrowheads" similar to those originally observed by Huxley with muscle acto-HMM (17).Another indication that the molecular basis of many forms of movement may be related comes from studies using the drug cytochalasin B. This alkaloid, a metabolite of the fungus Helminthosporium dematioideum (18), inhibits a wide variety of cellular movements (18)(19)(20). To our knowledge, nothing is known about the mode of action of cytochalasin B at the molecular level.Since actomyosin-like proteins and cytochalasin B have both been implicated in cellular movement in several orgaAbbreviations: Actin, filamentous actin or F-actin (the monomer is specified as G-actin); CB-actin, actin saturated with cytochalasin B; Me2SO, dimethyl sulfoxide; HMM, heavy meromyosin (a proteolytic fragment of myosin retaining ATPase activity and the ability to interact with actin). 442 nisms, we have begun to investigate whether cytochalasin B inhibits movement by interacting with actomyosin-like proteins. We report here that cytochalasin B interacts with purified muscle actin and that it appears to compete with myosin for binding to the actin. experiments. In the first, the actomyosin complex was formed before the addition of cytochalasin; in thie second, the actomyosin complex was formed after the addition of cytochalasin.The results of the first experiment were as follows (Fig. 1, open circles). Addition of actin to myosin in a 5:1 molar ratio caused an increase in the viscosity of the solution to a value